WUXI BIOLOGICS DL-,000025 Forum: Community User: Summer.76

https://www.genengnews.com/insights/bioprocessing-4-0-from-a-contract-manufacturing-perspective/

https://www.thepharmaletter.com/article/wuxi-biologics-expedites-global-expansion-while-facing-uncertainties

https://finance.yahoo.com/news/dyadic-announces-nonexclusive-research-license-130000690.html

https://www.prnewswire.com/news-releases/wuxi-biologics-achieved-remarkable-results-in-2019-301030370.html WuXi Biologics erzielte 2019 bemerkenswerte Ergebnisse

https://www.bizjournals.com/sanfrancisco/news/2020/03/25/covid-19-coronavirus-drug-vir-biotechnology.html

MESSAGE FROM CHRIS CHEN, CEO ON THE STATUS OF WUXI BIOLOGICS AND COVID-19 https://www.wuxibiologics.com/message-chris-chen-ceo-status-wuxi-biologics-covid-19/

https://www.businessinsider.de/wissenschaft/gesundheit/coronavirus-auf-diese-medikamente-setzen-wissenschaftler-derzeit-ihre-groessten-hoffnungen/ ... Vir Biotechnology hat Antikörper aus dem Blutserum von Patienten gewonnen, die 2003 eine SARS-Infektion überstanden haben. Nun prüft das Unternehmen, ob diese auch imstande sind, die Ausbreitung des nah verwandten aktuellen Coronavirus zu unterbinden. Für die biotechnische Produktion von „Kopien“ dieser Antikörper arbeitet Vir Biotechnology mit dem chinesischen Unternehmen WuXi Biologics zusammen. ...

WuXi Biologics Dundalk, Ireland February 2020 time-lapse https://youtu.be/e7oPKV_07VY

*** = t.elegram (ohne Punkt)

BRIEF-Wuxi Biologics Cayman Expects Profit Attributable For Year Will Increase More Than 58% https://www.reuters.com/article/brief-wuxi-biologics-cayman-expects-prof-idUSFWN2AW11S

👍

Vir Biotechnology und WuXi Biologics kündigen Partnerschaft zur Entwicklung von Coronavirus-Impfstoffen an.

*** = tele.gram (ohne Punkt dazwischen...)

https://www.eventbrite.com/e/let-science-lead-a-special-online-forum-on-covid-19-tickets-95310824241 In light of the evolving COVID-19 outbreak, WuXi AppTec is organizing a 3-hour complimentary virtual forum entitled “Let Science Lead: A Special Online Forum on COVID-19” on Tuesday, February 25 at 5pm-8pm PST/8pm-11pm EST (February 26 at 9am-12pm Beijing time). 5:50 – 6:40 PST Expediting Therapeutic Intervention u.a. mit Chris Chen, CEO of WuXi Biologics; Chairman, WuXi Vaccines This special forum will feature distinguished researchers and industry leaders with rich experience in infectious diseases, and who are leading efforts in the fight against COVID-19. Speakers will select questions from pre-event submission and address them during the live event. We encourage you to submit your questions to the panelists during the online registration process.